Cellebrite DI Ltd. updated revenue guidance for the full year 2023. For the period, the company now expected revenue to be between $310 million and $320 million as compared to $305 million to $315 million, Original Expectations(first issued on February 15,2023).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.66 USD | +1.33% | -3.96% | +23.09% |
24/05 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
24/05 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.09% | 218.8Cr | |
+8.91% | 8.59TCr | |
+5.14% | 7.79TCr | |
-16.20% | 5.29TCr | |
+26.18% | 4.83TCr | |
+28.93% | 4.54TCr | |
-34.05% | 4.08TCr | |
+66.72% | 3.88TCr | |
-0.36% | 2.75TCr | |
-26.47% | 2.15TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI Ltd. Updates Revenue Guidance for the Full Year 2023